This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Filling March Madness in "Sweet 16" Brackets of ETFs
by Sweta Killa
The excitement surrounding the tournament and its impact on the stock world has led investors to look at ETFs that could act as a proxy for the game.
U.S. Equity & ARK ETFs Top Last Week Inflows, Bonds Lag
by Sweta Killa
Overall, ETFs gathered about $11.5 billion capital last week, bringing in year-to-date inflows of $129.3 billion and higher than $98.3 billion seen in the year-ago period.
Weekly ETF Roundup: U.S. Equity Tops, Bond Flops
by Sweta Killa
Overall ETFs gathered about $36.3 billion capital last week, bringing in year-to-date inflows of $117.4 billion, higher than the $89.1 billion seen in the year-ago period,
Weekly ETF Roundup: Silver Rocks, U.S. Equity Lags
by Sweta Killa
Here are the ETFs leading in terms of asset flow last week and the ones lagging behind.
January ETF Asset Report
by Sanghamitra Saha
U.S. stocks and total market bonds amassed solid assets in the month of January.
10 Most-Heavily Traded ETFs of Q4
by Sweta Killa
We have highlighted 10 ETFs that have seen higher average volumes over the past three months and are thus the top 10 fund by trading volume.
Is This the Time to Buy High-Yielding ETFs?
by Sanghamitra Saha
With yields so low, certain risk-on sentiments can probably be exercised even with the bond investing. High-dividend paying equity ETFs are too great options.
ETF Asset Flow for November
by Sanghamitra Saha
U.S. stocks were super steady in November on back-to-back upbeat vaccine update.
ETF Strategies to Play as Vaccine Hopes Firm With Moderna Data
by Sanghamitra Saha
It???s been really a sweet November for the global economy and markets thanks to back-to-back release of upbeat coronavirus vaccine data from Moderna and Pfizer.
Last Week Saw Record Weekly Inflow: Top & Flop ETFs
by Sanghamitra Saha
News that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 news infused $44.5 billion into the stock market last week -- its biggest weekly inflow ever, per BofA, as quoted on MarketWatch.